Page results
-
Acute loss of sense of smell should be considered globally as a criterion for self-isolation, testing, and contact tracing for Covid-19 infection according to researchers at UCLH and UCL.
-
Elderly patients suffering the most common type of heart attack may benefit from more invasive treatment, new research involving UCLH has shown.
-
Five cases of Alzheimer’s disease are believed to have arisen as a result of medical treatments decades earlier, reports a team of UCL and UCLH researchers.
-
A pioneering breast cancer therapy developed by UCLH and UCL, which requires just one shot of radiotherapy rather than conventional weeks-long treatment, has proven to be as effective for most women in treating the disease.
-
NHS England has published a proposed interim specification for the new services for children and young people experiencing gender dysphoria.
-
Having proton beam therapy: information for children aged 9-12 patient information
-
As World Lung Cancer Day approaches (1 August) the SUMMIT Study reports that it has made great strides in catching up with patients whose nodule follow ups were cancelled due to COVID-19.
-
From the 23rd January, there will be a staggered rollout of the Tandem t:slim™ 7.7 Control IQ software.
-
A new surgical technique could remove the risk of urinary incontinence after surgery to remove the prostate for men with prostate cancer.
-
Penile plication (Nesbit) procedure post-operative information
File results
-
FOI/2023/0224 - Patients prescribed medical equipment for use in the home
-
FOI/2023/0222 - Contact details for senior screening and immunisations staff
-
FOI/2023/0220 - Internally produced patient information leaflets
-
FOI/2023/0218 - System for discharge letters, diagnostic reporting, digital dictation & bed management
-
FOI/2023/0217 - Integration platform(s) at the Trust
-
FOI/2023/0110 - General anaesthesia paediatric dental waiting times
-
FOI/2023/0115 - Deaths in A&E
-
FOI/2023/0114 - Electronic Patient Record/ Electronic Health Record systems
-
FOI/2023/0111 - Migraine treatment
-
FOI/2023/0117 - EPRR Team contact information